These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Ambulant treatment of peripheral circulation disorders of the legs with phosaden]. HARTH V Med Klin; 1958 Jul; 53(30):1309-11. PubMed ID: 13565343 [No Abstract] [Full Text] [Related]
3. Adenylic therapy and vascular disease; a preliminary report on the administration of muscle adenylic acid in vascular disease with special attention to the post-thrombotic and post-phlebitic syndromes of the lower extremities. O'BRIEN FL; TOSI GA; BRUNELLE AR J Natl Assoc Chirop; 1956 Jun; 46(6):376-82. PubMed ID: 13320110 [No Abstract] [Full Text] [Related]
4. [Results of treatment with adenosine-5-monophosphoric acid in various vascular disorders]. GUGEL-FRANK M Med Klin; 1957 Nov; 52(46):2004-5. PubMed ID: 13493008 [No Abstract] [Full Text] [Related]
5. Treatment of chronic venous insufficiency. SELIGMAN B J Ky State Med Assoc; 1956 Jun; 54(6):524-7. PubMed ID: 13319871 [No Abstract] [Full Text] [Related]
7. [Radioprotective effect of nucleosides and nucleotides and the mechanism of action of adenosine]. Kulinskiĭ VI; Klimova AD; Filippovich IV Radiobiologiia; 1988; 28(2):230-5. PubMed ID: 3363102 [TBL] [Abstract][Full Text] [Related]
8. A hydrostatic pressure stocking for the treatment of ulcers due to chronic venous insufficiency. WOOD JE Circulation; 1959 Dec; 20():1043-8. PubMed ID: 13845820 [No Abstract] [Full Text] [Related]
9. Muscle adenylic acid as an adjunct to prepare patients with phlebitis and ulcers for definitive surgery. PRATT GH Am J Surg; 1959 Jun; 97(6):696-7. PubMed ID: 13650067 [No Abstract] [Full Text] [Related]
10. [Clinical experiences with adenosine-5-monophosphoric acid in different dermatoses]. SCHREINER HE Ther Ggw; 1958 Feb; 97(2):53-7. PubMed ID: 13543795 [No Abstract] [Full Text] [Related]
11. Nucleosides and nucleotides: past, present, and future. Robins RK Ann N Y Acad Sci; 1975 Aug; 255():597-610. PubMed ID: 171998 [No Abstract] [Full Text] [Related]
12. [Experience with adenosine-5-monophosphoric acid in the therapy of spondylosis deformans]. BRUCKNER C; SIMON J Ther Ggw; 1958 Dec; 97(12):505-7. PubMed ID: 13615753 [No Abstract] [Full Text] [Related]
13. [Therapeutic possibilities in progressive muscular dystrophy]. Beckmann R; von Osten V Dtsch Med Wochenschr; 1966 Jan; 91(3):108-16. PubMed ID: 5901816 [No Abstract] [Full Text] [Related]
14. [Therapy of heart disease in general practice]. SCHENK H Med Klin; 1958 Nov; 53(48):2075-6. PubMed ID: 13612711 [No Abstract] [Full Text] [Related]
15. [New aspects of the management of progressive muscular dystrophy]. Tilscher H; Schenk S Wien Med Wochenschr; 1967 Nov; 117(44):1000-2. PubMed ID: 5591872 [No Abstract] [Full Text] [Related]
16. [Long term results of intraarterial infusion therapy in peripheral arterial occlusive diseases]. Hild R; Spaan G; Stein U Med Welt; 1981 Apr; 32(14):448-51. PubMed ID: 7219157 [No Abstract] [Full Text] [Related]
17. Nucleosides and nucleotides as potential therapeutic agents. Shen TY Angew Chem Int Ed Engl; 1970 Sep; 9(9):678-88. PubMed ID: 4990680 [No Abstract] [Full Text] [Related]
18. [Association of coronarodilatory & cardiotrophic drugs in the treatment of coronary insufficiency]. FAUDA C; GRIGOLATO V; CANDIANI C Minerva Med; 1959 Mar; 50(22):791-7. PubMed ID: 13656696 [No Abstract] [Full Text] [Related]
19. Chronic venous insufficiency of the lower extremity. CRANLEY JJ; KRAUSE RJ; STRASSER ES Surgery; 1961 Jan; 49():48-58. PubMed ID: 13696275 [No Abstract] [Full Text] [Related]
20. Strategies for reducing intestinal atrophy during total parenteral nutrition: role of intravenous nucleosides and nucleotides. Shenkin A Nutrition; 1994; 10(2):203-4. PubMed ID: 8025383 [No Abstract] [Full Text] [Related] [Next] [New Search]